Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vertex Pharmaceuticals (VRTX) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (418)	5/17/2000 12:31:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1169

>> And, once again -- review the thread -- we're all left saying "thanks Miljenko!" << and "thanks Jim Silverman!" TD.... Ph.D., long-time contributor to SI biotech, organic chemist. MZ.... Ph.D., organic chemist, long-time contributor to SI biotech. PB.... Ph.D., molecule jockey, long-time contributor to SI biotech. BJ.... Ph.D., biochemist/mol. biologist/whathaveyou, long-time contributor to SI biotech. biowa, Ph.D., biochem. something or other., long-time contributor to SI biotech. Casaubon, Bags, and on and on. Quite a cast of scientists thrown at this thread. Boger et al...... you're getting quite a bit of respect from all sides. Please bring it on home.

To: scaram(o)uche who wrote (418)	5/24/2000 8:40:00 PM
From: Miljenko Zuanic	Respond to of 1169

<<I love this deal. I'd share MZ's cautious "wait and see", if not for the breadth of the VRTX business plan and the relevant preclinical work to date.>> Surely I wish that Novartis did accepted bit higher their own risk in this deal. Currently they are among leaders in kinase field, so VRTX must be very confident with their own R&D programs. If I do not believe in VRTX capability, this deal will be at half value (for me), as it is presented. Regards today news, one thing is certain: characteristic of all bios is that they will not let you sleep too well too long!